Thomas Egebjerg

988 total citations
12 papers, 447 citations indexed

About

Thomas Egebjerg is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Thomas Egebjerg has authored 12 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Thomas Egebjerg's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Protein purification and stability (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Thomas Egebjerg is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Protein purification and stability (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Thomas Egebjerg collaborates with scholars based in Denmark, United States and United Kingdom. Thomas Egebjerg's co-authors include Pieter Spee, Luis J. Sigal, Lewis L. Lanier, Min Fang, Mark T. Orr, Jais Rose Bjelke, Nikolai Lorenzen, Ida Hilden, Mirella Ezban and Albrecht Gruhler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Thomas Egebjerg

12 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Egebjerg Denmark	7	127	127	87	74	47	12	447
Silke Roscher United Kingdom	7	63 0.5×	298 2.3×	85 1.0×	38 0.5×	54 1.1×	10	447
Rachel S. Wallace New Zealand	6	70 0.6×	187 1.5×	119 1.4×	17 0.2×	22 0.5×	7	333
Mafalda Lopes‐da‐Silva United Kingdom	13	122 1.0×	99 0.8×	165 1.9×	16 0.2×	17 0.4×	18	479
Mahyar Ostadkarampour Sweden	10	20 0.2×	111 0.9×	173 2.0×	17 0.2×	66 1.4×	16	448
Romy Kronstein‐Wiedemann Germany	7	63 0.5×	49 0.4×	72 0.8×	104 1.4×	31 0.7×	17	297
Patricia Fuentes Spain	14	37 0.3×	93 0.7×	203 2.3×	169 2.3×	32 0.7×	27	475
H. Robinson United States	4	32 0.3×	182 1.4×	121 1.4×	62 0.8×	84 1.8×	5	365
Richard E. Broadberry Taiwan	14	361 2.8×	57 0.4×	185 2.1×	43 0.6×	59 1.3×	25	570
S Yamaguchi Japan	10	262 2.1×	132 1.0×	203 2.3×	22 0.3×	70 1.5×	20	503
Ryan J. Norton United States	8	49 0.4×	135 1.1×	74 0.9×	18 0.2×	26 0.6×	12	587

Countries citing papers authored by Thomas Egebjerg

Since Specialization

Citations

This map shows the geographic impact of Thomas Egebjerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Egebjerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Egebjerg more than expected).

Fields of papers citing papers by Thomas Egebjerg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Egebjerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Egebjerg. The network helps show where Thomas Egebjerg may publish in the future.

Co-authorship network of co-authors of Thomas Egebjerg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Egebjerg. A scholar is included among the top collaborators of Thomas Egebjerg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Egebjerg. Thomas Egebjerg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Fischer, Felix R., Tuan Anh Nguyen, Thomas Egebjerg, et al.. (2025). Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics. Molecular Pharmaceutics. 22(11). 6636–6645. 1 indexed citations

Bayarri‐Olmos, Rafael, Anne Rosbjerg, Charlotte Helgstrand, et al.. (2024). Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses. Frontiers in Immunology. 15. 1412873–1412873. 1 indexed citations

Dingfelder, Fabian, Jais Rose Bjelke, S. Grell, et al.. (2024). A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs. mAbs. 16(1). 2403156–2403156. 5 indexed citations

Ausserwӧger, Hannes, Georg Krainer, Timothy J. Welsh, et al.. (2023). Surface patches induce nonspecific binding and phase separation of antibodies. Proceedings of the National Academy of Sciences. 120(15). e2210332120–e2210332120. 16 indexed citations

Herling, Therese W., Gaetano Invernizzi, Hannes Ausserwӧger, et al.. (2023). Nonspecificity fingerprints for clinical-stage antibodies in solution. Proceedings of the National Academy of Sciences. 120(52). e2306700120–e2306700120. 3 indexed citations

Narayanan, Harini, Fabian Dingfelder, Jais Rose Bjelke, et al.. (2021). Design of Biopharmaceutical Formulations Accelerated by Machine Learning. Molecular Pharmaceutics. 18(10). 3843–3853. 53 indexed citations

Farkas, Erzsébet, Anett Szilvásy‐Szabó, Morten G. Rasch, et al.. (2020). Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain. Brain Structure and Function. 226(1). 225–245. 48 indexed citations

Hansen, Cecilie Bo, Ida Jarlhelt, Laura Pérez‐Alós, et al.. (2020). SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals. The Journal of Immunology. 206(1). 109–117. 68 indexed citations

Enoksson, Mari, Erika J. Martin, Mette S. Jensen, et al.. (2019). Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets. Journal of Thrombosis and Haemostasis. 18(1). 104–113. 4 indexed citations

10.

Hilden, Ida, Brian Lauritzen, Brit B. Sørensen, et al.. (2012). Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood. 119(24). 5871–5878. 121 indexed citations

11.

Fang, Min, Mark T. Orr, Pieter Spee, et al.. (2011). CD94 Is Essential for NK Cell-Mediated Resistance to a Lethal Viral Disease. Immunity. 34(4). 579–589. 86 indexed citations

12.

Orr, Mark T., Jun Wu, Min Fang, et al.. (2010). Development and Function of CD94-Deficient Natural Killer Cells. PLoS ONE. 5(12). e15184–e15184. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact